Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Regulatory News (SPH)

  • There is currently no data for SPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Jan 2018 14:15

RNS Number : 0385C
Sinclair Pharma PLC
16 January 2018
 

Sinclair Pharma plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

London, 16 January 2018 Sinclair Pharma plc (AIM:SPH.L) ("Sinclair" or the "Group"), the international aesthetics company, was advised on 16 January 2018, that today, Julie Spooner, wife of Chris Spooner, Chief Executive Officer, acquired 200,000 ordinary shares of 1p each ("Ordinary Shares") in the Group at an average price of 23.15p per Ordinary Share.

Following these purchases, Chris Spooner's total beneficial interest is 10,440,479 Ordinary Shares, 2.07% of the issued share capital of the Group.

For further information please contact:

Sinclair Pharma plc

Tel: +44 (0) 20 7467 6920

Chris Spooner 

Alan Olby

Andy Crane

 

Peel Hunt LLP (NOMAD and Joint Broker)

Tel: +44 (0) 20 7418 8900

James Steel

Oliver Jackson

 

RBC Capital Markets (Joint Broker)

Tel: +44 (0) 20 7653 4000

Marcus Jackson

Laura White

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Julie Spooner

2.

Reason for the notification

a.

Position/status

Wife of Chris Spooner, Chief Executive Officer

b.

Initial notification

/Amendment

Initial Announcement

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Sinclair Pharma plc

b.

LEI

213800BNMD7JVMHW1772

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary Shares of 1 pence each in Sinclair Pharma plc

 

 

 

GB0033856740

b.

Nature of the transaction

Purchase

 

c.

Price(s) and volume(s)

 Price(s)

 

Volume(s)

23.15p

200,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

N/A

 

e.

Date of the transaction

2018-01-16

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZQLFFVFFFBBX
Date   Source Headline
5th May 20162:13 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
5th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th May 20163:00 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
4th May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd May 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
3rd May 201610:51 amPRNForm 8.3 - Sinclair Pharma Plc
3rd May 20167:00 amRNSForm 8.3 - SINCLAIR PHARMA PLC
29th Apr 20165:56 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma REPLACEMENT
29th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
28th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
25th Apr 201612:00 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
22nd Apr 201611:58 amBUSForm 8.3 - Sinclair Pharma Plc
21st Apr 201610:30 amPRNForm 8.3 - Sinclair Pharma Plc
21st Apr 20169:19 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
20th Apr 201611:24 amBUSForm 8.3 - Sinclair Pharma Plc
20th Apr 20168:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
19th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Apr 201611:30 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
15th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
14th Apr 20161:37 pmRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
13th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
12th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma PLC
11th Apr 201610:17 amPRNForm 8.3 - Sinclair Pharma Plc
11th Apr 20169:13 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
8th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC)
7th Apr 20162:19 pmRNSForm 8.3 - [Sinclair Pharma plc]
7th Apr 201611:58 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
6th Apr 20162:34 pmRNSForm 8.3 - [Sinclair Pharma plc]
6th Apr 20169:34 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
5th Apr 20162:49 pmRNSForm 8.3 - [Sinclair Pharma plc]
5th Apr 20169:18 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
4th Apr 20162:51 pmRNSForm 8.3 - [Sinclair Pharma plc]
4th Apr 201610:26 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
1st Apr 20163:44 pmRNSForm 8.3 - [Sinclair Pharma plc]
1st Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
31st Mar 20161:09 pmRNSForm 8.3 - [Sinclair Pharma plc]
31st Mar 201610:54 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
30th Mar 201610:31 amPRNForm 8.3 - Sinclair Pharma Plc
30th Mar 201610:00 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
30th Mar 20167:00 amRNSHalf Yearly Report
30th Mar 20167:00 amRNSAmendment to AQTIS Acquisition Contract Agreed
29th Mar 201611:59 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
29th Mar 201611:21 amPRNForm 8.3 - Sinclair Pharma plc
24th Mar 20161:21 pmRNSNotice of Results
24th Mar 201610:20 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
23rd Mar 201610:22 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
22nd Mar 20163:03 pmRNSForm 8.3 - SINCLAIR PHARMA PLC
22nd Mar 20169:24 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
21st Mar 201611:05 amRNSForm 8.5 (EPT/RI) - Sinclair Pharma Plc
18th Mar 20165:39 pmRNSRobert Stuart Swanson - Form 8.3 - Sinclair Pharma

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.